Alex Zisson News Today

New York, NY (PRWEB) January 10, 2023 -- - Makes major investment in Phase 2b Clinical Trial at NFlection Therapeutics- Topical MEK inhibitor NFX-179 Shows

Watanabe brings deep experience in healthcare and medical devicesSTAMFORD, Conn.--(BUSINESS WIRE)--#BoardMember--H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $47 billion of equity capital under management, is pleased to announce that Gwen Watanabe has joined the firm’s dedicated...